The detection and management of complications following the treatment of liver metastases. Issue 9 (September 2022)

• Record Type: Journal Article
• Authors: Walsh, Caoimhe; Cresswell, Adrian Ben
• Is Part Of: Surgery. Volume 40:Issue 9(2022)
• Page Start: 593
• Page End: 600
• Publication Date: 2022-09
• Subjects: Liver abscess -- liver embolization -- liver metastases -- liver resection -- microwave ablation -- selective radiotherapy; Surgery -- Periodicals; Surgery -- Periodicals; Chirurgie -- Périodiques; Thérapeutique -- Périodiques; Electronic journals; 617
• DOI: 10.1016/j.mpsur.2022.06.002
• Languages: English
• ISSNs: 0263-9319

Abstract

Abstract: Whilst once considered as incurable systemic disease, treatment options for liver metastases have increased over the last 30 years and safety has improved dramatically, such that for a selected group of patients the hope of cure can now be offered with radical treatment and low morbidity interventions can be offered which prolong survival, even in patients with more widely disseminated disease. Advances have been made in selection and surgical technique for liver resection and several adjuncts to resection now exist in the form of portal vein embolization, thermal ablation and targeted drug or radiotherapy delivery options. A natural consequence of these developments has been the delivery of services within fewer specialist units, with the result that later complications of therapy may present to local hospitals, rather than directly to the specialist centres. This article will describe the current common liver directed therapies and outline the presentation and management of their complications.